scholarly journals Clinico-radiologic Findings in Group II Caudal Regression Syndrome

2013 ◽  
Vol 3 ◽  
pp. 26 ◽  
Author(s):  
Pankaj Sharma ◽  
Sheo Kumar ◽  
Awdesh Jaiswal

Caudal regression syndrome (CRS) is a rare congenital abnormality in which a segment of the lumbo-sacral spine and spinal cord fails to develop. The severity of the morphologic derangement inversely correlates with residual spinal cord function. We present a case report of a 10-year-old girl with Group 2 CRS, to emphasize clinical and radiologic findings in this rare abnormality.

2017 ◽  
Vol 15 (2) ◽  
pp. 57-60
Author(s):  
Sadia Afrin Mony ◽  
Tanuka Barua ◽  
Md Badruddoza

Caudal Regression Syndrome (CRS) is a spectrum of congenital malformations, which consist of anomalies of the rectum, the urinary and genital systems, the lumbosacral spine, and the lower limbs. Though exact cause that leads to caudal regression syndrome is still unknown but it is believed that genetic influence as well as maternal pathologic factor related to carbohydrate metabolism plays an important role. The severity of morphologic disorder depends on residual spinal cord function. Infant may present with mild to severe neurological involvement with or without visceral anomaly. Here, we report a case of caudal regression syndrome in an 18 months old girl and presented with hypoplastic lower limb and bladder incontinence.Chatt Maa Shi Hosp Med Coll J; Vol.15 (2); Jul 2016; Page 57-60


Author(s):  
Jesús Devesa ◽  
Alba Alonso ◽  
Natalia López ◽  
José García ◽  
Carlos Israel Puell ◽  
...  

Caudal regression syndrome (CRS) is a congenital abnormality characterized by an incomplete development of the spinal cord (SC) and other abnormalities. We studied a 9-months old CRS child presenting: interruption of SC at L2-L3 level, sacral agenesis, lack of innervation of the inferior limbs (flaccid paraplegia) and neurogenic bladder and bowel. Given the effects of growth hormone (GH) on the proliferation, differentiation and migration of neural stem cells (NSCs), we treated him with GH and rehabilitation, trying to induce the recovery of main sequelae. GMFM-88 test score was 12.31%. After a blood analysis, GH treatment (0.3 mg/day, 5 days/week, 3 months and then 15 days without GH) and rehabilitation commenced. This protocol was followed during 5 years, being the last GH dose 1 mg/day. Blood analysis and physical exams were performed every 3 months initially and every 6 months later. Six months after commencing the treatment GMFM-88 score increased to 39.48%. Responses to sensitive stimuli appeared in most of the territories explored; 18 months later sensitive innervation was complete and the patient moved any muscle over the knees and controlled his sphincters. Three years later he walked with the help of canes, there was plantar flexion and GMFM-88 score was 78.48%. In summary, GH plus rehabilitation may be useful for innervating distal territories, below the level of the incomplete spinal cord in CRS. Most likely, GH acts on ependymal SC NSCs, as the hormone does in the neurogenic niches in the brain.


2011 ◽  
Vol 38 (S1) ◽  
pp. 203-203 ◽  
Author(s):  
A. Soria ◽  
J. Iglesias ◽  
G. Villagomez Martinez ◽  
G. Castillo ◽  
J. Villarreal ◽  
...  

2020 ◽  
Vol 53 (4) ◽  
pp. 509-511
Author(s):  
Dany Hage ◽  
Joe Iwanaga ◽  
Aaron S. Dumont ◽  
R. Shane Tubbs

2006 ◽  
Vol 88 (2) ◽  
pp. 163-164 ◽  
Author(s):  
KP Kennedy ◽  
S Barnard ◽  
MJ Speakman

Splenogonadal fusion is a rare congenital abnormality. In this case report, the diagnosis of splenogonadal fusion was made after the removal of an abnormal mass at ‘routine’ left herniotomy. A cautious approach at surgery resulted in no apparent damage to the testicle. A short review of the literature is included.


2015 ◽  
Vol 41 (4) ◽  
pp. S111
Author(s):  
Thiago Kerber Correa ◽  
Juliana Gevaerd Martins ◽  
Usha Verma

Author(s):  
Sendhil A ◽  
Sunitha C ◽  
Vasavi Kolluru ◽  
Janani Shankar

Sign in / Sign up

Export Citation Format

Share Document